LAURA HICKS: Open Payments
NPI 1902545080 · CANAL WINCHESTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 72 payments from 25 companies in 2025. Trend: 2023 $863 · 2024 $1,361 · 2025 $1,243
Food & beverage: $1,243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $175 |
| Novo Nordisk Inc | 12 | $168 |
| PFIZER INC. | 6 | $116 |
| Lilly USA, LLC | 5 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $81 |
| Astellas Pharma US Inc | 2 | $57 |
| GlaxoSmithKline, LLC. | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Collegium Pharmaceutical, Inc. | 3 | $42 |
Products named: Ozempic, Kerendia, MOUNJARO, QULIPTA, ELIQUIS, VRAYLAR, REXULTI, Veozah.
Industry payments across OH — which companies pay providers there.
